[1]刘义宁,余丹阳,孙铁英,等.中国1998至2007年临床确诊肺真菌病的多中心回顾性调查.中华结核和呼吸杂志,2011,34(2):86-90. [2]De Pauw B,Walsh TJ,Donnelly JP,et a1.Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group(EORTC/MSG) Consensus Group.Clin Infect Dis,2008,46(12):1813-1821. [3]中华内科杂志编辑委员会.侵袭性肺部真菌感染的诊断标准与治疗原则(草案).中华内科杂志,2006,45(8):697-700. [4]Kami M,Kishi Y,Hamaki T, et al. The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis.An autopsy-based retrospective study of 48 patients. Mycoses,2002,45(8): 287-294. [5]中华医学会呼吸病学分会感染学组,中华结核和呼吸杂志编辑委员会.肺真菌病诊断和治疗专家共识.中华结核和呼吸杂志,2007,30(11):821-834. [6]Limper AH,Knox KS,Sarosi GA,et a1. An official American Thoracic Society statement:Treatment of fungal infections in adult pulmonary and critical care patients.Am J Respir Crit Care Med,2011,183(1):96-128. [7]Dodds Ashley ES, Lewis R, Lewis JS, et al. Pharmacology of systemic antifungal agents. Clin Infect Dis, 2006, 43 Suppl 1: S28-39. |